Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era

Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era

Purpose: To analyze the difference in the prediction accuracy with an active surveillance (AS) protocol between two eras (pre-International Society of Urological Pathology [pre-ISUP]-2014 vs. post-ISUP2014). Materials and Methods:Materials and Methods: We retrospectively analyzed 118 candidates for...

Full description

Bibliographic Details
Main Authors:	Mun Su Chung, Nam Hoon Cho, Jinu Kim, Youngheun Jo, Byung Il Yoon, Seung Hwan Lee
Format:	Article
Language:	English
Published:	Korean Society for Sexual Medicine and Andrology 2021-07-01
Series:	The World Journal of Men's Health
Subjects:	neoplasm grading prostatectomy prostatic neoplasms watchful waiting

Similar Items

Current status of active surveillance in prostate cancer
by: Mun Su Chung, et al.
Published: (2016-01-01)

Prognostic value of the ISUP 2015 Gleason grade groupings
by: Folkvaljon, Yasin
Published: (2015)

The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective study
by: Liu J, et al.
Published: (2019-07-01)

Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy
by: Yuta Takeshima, et al.
Published: (2021-05-01)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
by: Wan Song, et al.
Published: (2019-11-01)

A Comparative Histopathologic Analysis of Prostatic Carcinomas by Conventional and 2005 ISUP Modified Gleason Systems
by: Deborah Dalmeida, et al.
Published: (2018-12-01)

A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
by: Sang Hun Song, et al.
Published: (2021-01-01)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
by: Min Ji Jeon, et al.
Published: (2021-08-01)

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up
by: Ji Yong Ha, et al.
Published: (2017-05-01)

Active surveillance for nonmuscle invasive bladder cancer
by: Makito Miyake, et al.
Published: (2016-06-01)

A Neural Network Model Based on Enhanced CT for Distinguishing ISUP Grade of Clear Cell Renal Cell Carcinoma
by: HAN Dong, et al.
Published: (2021-01-01)

Super active surveillance for low-risk prostate cancer | Opinion: Yes
by: Leonardo O. Reis, et al.

Super active surveillance for low-risk prostate cancer | Opinion: No
by: Saum Ghodoussipour, et al.

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
by: Chang Wook Jeong, et al.
Published: (2014-12-01)

MRI should be routine for all patients with localized prostate cancer? | Opinion: No
by: Joel B. Nelson

MRI should be routine for all patients with localized prostate cancer? | Opinion: Yes
by: Ronaldo Hueb Baroni

Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies
by: Malte W. Vetterlein, et al.
Published: (2016-07-01)

Midterm MRI Follow-Up of Untreated Enchondroma and Atypical Cartilaginous Tumors in the Long Bones
by: Claudia Deckers, et al.
Published: (2021-08-01)

Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy
by: Irai S. Oliveira, et al.
Published: (2010-06-01)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
by: Hanfeng Wang, et al.
Published: (2017-09-01)

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
by: Duc Minh Pham, et al.
Published: (2020-07-01)

Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance
by: Zambrano Norman, et al.
Published: (2014-04-01)

Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation
by: Xiaochuan Wang, et al.
Published: (2021-01-01)

Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
by: Hongzoo Park, et al.
Published: (2020-01-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Nishanth Krishnananthan, et al.
Published: (2016-06-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Henk G. van der Poel, et al.
Published: (2016-06-01)

Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system
by: Hugo Pontes Antunes, et al.
Published: (2018-09-01)

Predictive criteria of insignificant prostate cancer: what is the correspondence of linear extent to percentage of cancer in a single core?
by: Athanase Billis, et al.
Published: (2015-04-01)

Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males
by: Min Ho Lee, et al.
Published: (2020-01-01)

Longitudinal monitoring of the course of depressive disorders: Careful monitoring of the course of depressive episode
by: Kostić Milutin, et al.
Published: (2020-01-01)

WHO/ISUP classification of the urothelial tumors of the urinary bladder
by: Zdenka Ovčak
Published: (2005-09-01)

Does tumor extent on needle prostatic biopsies influence the value of perineural invasion to predict pathologic stage > T2 in radical prostatectomies?
by: Athanase Billis, et al.
Published: (2010-08-01)

CRTC2 as a novel prognostic biomarker for worse pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with prostate cancer
by: Hakmin Lee, et al.
Published: (2019-03-01)

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
by: Athanase Billis
Published: (2010-10-01)

Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer
by: Dharam Kaushik, et al.

Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions
by: Bashir Al Hussein Al Awamlh, et al.
Published: (2021-05-01)

The Impact of the Ongoing COVID-19 Epidemic on the Increasing Risk of Adverse Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy
by: Baranek, P., et al.
Published: (2022)

The ISUP system of staging, grading and classification of renal cell neoplasia
by: Hemamali Samaratunga, et al.
Published: (2014-07-01)

Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection
by: Okajima Eijiro, et al.
Published: (2012-11-01)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
by: Thiago N. Valette, et al.
Published: (2015-06-01)